Cystic hygroma is a condition that affects the lymphatic system, which is responsible for removing excess fluid from the body. This condition can cause swelling and pain in the neck, chest, and abdomen. It can also cause difficulty breathing, eating, and speaking. Though it is a rare condition, it is important to understand the causes and treatments for cystic hygroma in order to properly diagnose and treat it.
Cystic hygroma is a condition that affects the lymphatic system, which is responsible for removing excess fluid from the body. It is caused by a malformation of the lymphatic vessels, which causes them to become blocked and unable to function properly. This blockage causes a buildup of fluid in the affected area, resulting in swelling and pain. Cystic hygroma can affect any area of the body, but it is most commonly found in the neck, chest, and abdomen.
The most common symptom of cystic hygroma is swelling in the affected area. This swelling can cause pain, difficulty breathing, eating, and speaking. Other symptoms can include a feeling of fullness in the affected area, a lump or mass, and skin discoloration.
The exact cause of cystic hygroma is not known, but it is believed to be caused by a malformation of the lymphatic vessels. This malformation can be caused by a genetic mutation, an infection, or a trauma to the affected area. It is also possible for cystic hygroma to be caused by an underlying condition such as lymphoma or leukemia.
In order to diagnose cystic hygroma, a doctor will typically use imaging tests such as an ultrasound or MRI. These tests can help to identify the location and extent of the swelling. A biopsy may also be used to confirm the diagnosis.
The treatment for cystic hygroma depends on the severity of the condition and the underlying cause. In some cases, the condition may resolve on its own without treatment. However, if the condition does not improve or worsens, then treatment may be necessary.
In cases where the cystic hygroma is causing pain or difficulty breathing, eating, or speaking, surgery may be recommended. The goal of surgery is to remove the blockage in the lymphatic vessels and allow them to function properly. This can help to reduce the swelling and improve the symptoms.
In some cases, medication may be used to help reduce the swelling and improve the symptoms of cystic hygroma. These medications can include steroids, anti-inflammatory drugs, and antibiotics.
Radiation therapy can also be used to help reduce the swelling and improve the symptoms of cystic hygroma. This therapy uses high-energy X-rays to shrink the cyst and reduce the swelling.
Cystic hygroma is a condition that affects the lymphatic system and can cause swelling and pain in the neck, chest, and abdomen. The exact cause of the condition is not known, but it is believed to be caused by a malformation of the lymphatic vessels. Treatment for cystic hygroma depends on the severity of the condition and the underlying cause, but can include surgery, medication, and radiation therapy. It is important to understand the causes and treatments for cystic hygroma in order to properly diagnose and treat it.
1.
Data indicate 1 in 3 US adults unaware of connection between HPV and cancers
2.
Early Esophageal Cancer pCR Rates Are Raised by Neoadjuvant PD-1 Blockade.
3.
New imaging probe helps track prostate cancer and possibly treat it before resistance develops
4.
A novel blood test may enable the early identification of common, fatal cancers.
5.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
1.
What You Need to Know About the Early Warning Signs of Colon Cancer
2.
Uncovering the Hidden Picture: Using Ultrasound to Diagnose Breast Cancer
3.
Unlocking the Potential of Red Bone Marrow in the Formation of Blood Cells
4.
Unlocking the Potential of Reticulocytes: The Key to Enhanced Blood Production
5.
Unlocking the Potential of Polatuzumab for Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part X
2.
Navigating the Complexities of Ph Negative ALL - Part XII
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
4.
Role of Nimotuzumab in Management of Nasopharyngeal Cancer
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation